Prevalence and clinical significance of BRAF V600E in Chinese patients with lung adenocarcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|6|3|269-274

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.6, Iss.3, 2015-05, pp. : 269-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Prevalence and clinical characteristics of primary Sjogren's syndrome patients with lung cancer: An analysis of ten cases in China and literature review

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 475-479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of calcium sensing receptor and E‐cadherin correlated with survival of lung adenocarcinoma

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 754-760

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subsequent treatment of epidermal growth factor receptor‐tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 678-686

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China

By  

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 636-642

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological characteristics and outcomes of ROS1‐rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 413-420

John Wiley & Sons Inc

Access to resources Recommend Favorite